TrademarkDir
AXIUM BIORESEARCH DRUGEXAM AT HOME TESTING
LIVE

Serial Number

90811891

Owner

Axium BioResearch, Inc.

Attorney

Christopher J. Day

First Use Date

Sep 28, 2020

Filing Date

Jul 5, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

AXIUM BIORESEARCH DRUGEXAM AT HOME TESTING Trademark

Serial Number: 90811891 • Registration: 7328051

AXIUM BIORESEARCH DRUGEXAM AT HOME TESTING is a trademark filed by Axium BioResearch, Inc. on July 5, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Axium BioResearch, Inc. (5 trademarks)

2233 Faraday Ave, Suite A
CARLSBAD, CA 92008

Entity Type: 03

Trademark Details

Filing Date

July 5, 2021

Registration Date

March 12, 2024

First Use Anywhere

September 28, 2020

First Use in Commerce

September 28, 2020

Published for Opposition

May 31, 2022

Goods & Services

Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 12, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 12, 2024 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 6, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 3, 2024 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 29, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 29, 2024 CRFA
ASSIGNED TO LIE
Jan 29, 2024 ALIE
NOTICE OF REVIVAL - E-MAILED
Oct 17, 2023 NREV
PETITION GRANTED - RESPONSE RECEIVED
Oct 17, 2023 PGRR
ASSIGNED TO PETITION STAFF
Oct 17, 2023 APET
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 5, 2023 TROA
TEAS PETITION TO REVIVE RECEIVED
Sep 5, 2023 PROA
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Aug 31, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Aug 31, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Aug 31, 2023 ABN2
ASSIGNED TO EXAMINER
Aug 31, 2023 DOCK
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 6, 2023 GNRN
NON-FINAL ACTION E-MAILED
Apr 6, 2023 GNRT
SU - NON-FINAL ACTION - WRITTEN
Apr 6, 2023 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Mar 20, 2023 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 20, 2023 AITU
USE AMENDMENT FILED
Mar 1, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
Mar 1, 2023 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 29, 2022 NOAM
NEW NOA TO ISSUE
Oct 17, 2022 NEWN
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 28, 2022 NOAM
NOTICE OF ALLOWANCE CANCELLED
Jul 26, 2022 IUCN
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 31, 2022 NPUB
PUBLISHED FOR OPPOSITION
May 31, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 11, 2022 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 28, 2022 PREV
ASSIGNED TO LIE
Apr 25, 2022 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 22, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 22, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 22, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 22, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 22, 2022 CNEA
ASSIGNED TO EXAMINER
Mar 24, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 14, 2021 NWOS
NEW APPLICATION ENTERED
Jul 8, 2021 NWAP

Related Trademarks

More from this Owner

AXIUM BIORESEARCH, INC., DRUGEXAM THC ADVANTAGE MULTI-DRUG SCREEN DIP CARD

AXIUM BIORESEARCH, INC., DRUGEXAM THC ADVANTAGE MULTI-DRUG SCREEN DIP CARD

DRUGEXAM

DRUGEXAM